ESC 365 - How do we use anticoagulation therapy in the era of novel drugs - results of FIRST II registryy

HFA Premium Access

How do we use anticoagulation therapy in the era of novel drugs - results of FIRST II registryy

Session: Poster Session 3 - Drug therapy, other

Topic: Drug therapy, other

Speaker: Doctor T. Nociarova (Brno, CZ)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Doctor Tereza Nociarova

FNUSA, Brno (Czechia)

0 follower

9 more presentations in this session

Assessment of the use of ESC heart failure guideline recommended therapy among patients followed at a heart failure outpatient clinic participating in the ESC Heart Failure long-term Registry

Speaker: Doctor B. Muk (Budapest, HU)

Long-term follow up of hospitalized patients with systolic heart failure undergoing early treatment with beta-blockers more ivabradine: a randomized study

Speaker: Doctor F. Hidalgo Lesmes (Cordoba, ES)

Comparison of perindopril-amlodipine and losartan-amlodipine combinations in the management of hypertension in patients with metabolic syndrome

Speaker: Doctor J. Uzokov (Tashkent, UZ)

Cardioprotective effects of long-term high-dose therapy with atorvastatin in patients with STEMI in the prevention of chronic heart failure

Speaker: Professor V. Oleinikov (Penza, RU)

Mineralocorticoid receptor antagonists improve quality of life in patients with systolic heart failure highly treated with neurohormonal inhibitors: a propensity-score matching analysis

Speaker: Associate Professor D. Farmakis (Athens, GR)

Access the full session

Poster Session 3 - Drug therapy, other

Speakers: Doctor T. Nociarova, Doctor B. Muk, Doctor F. Hidalgo Lesmes, Doctor J. Uzokov, Professor V. Oleinikov...

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources